-The Times of India and other agencies WASHINGTON: United States President Donald Trump has promised to bring the cost of prescription drugs in the country "way down" and let other countries pay more for these medicines. If effected, Trump's new policy on prescription drugs, dicussed with his cabinet at the White House on Monday, could have grave implications for India. The US has long had a grouse with India over its patent...
More »SEARCH RESULT
Total Matching Records found : 112
India Scores Lowest Among BRICS on Health Sustainable Development Goal Index -Swagata Yadavar
-Factchecker.in With a score of 38.6 out of 100, India’s performance on health-related Sustainable Development Goals (SDGs) Index is the worst among BRICS nations. SDGs are universal targets including ending poverty, hunger and inequality, improving access to health and education among others for all countries by 2030. Created by the international research collaboration Global Burden of Disease, the SDG index calculates the performance of countries on 37 health-related targets of SDGs including under-five...
More »Govt washes hands off vaccine deaths
-DNA Of 132 AEFI cases, only 78 babies survived and 54 died, a Union Health Ministry report says A string of deaths has put a question mark on the safety of India's child vaccination programme. And the central government seems to be washing its hands of these post-vaccination casualties. In December last year, 45-day-old baby girl Aarohi Bajgude died in Maharashtra's Beed district, three hours after receiving the dose of Pentavalent vaccine....
More »Modi Government Halves Spending On Maternity Benefit Programme
-PTI Pregnant women and lactating mothers are eligible to receive a cash benefit of Rs. 5,000 in three instalments. New Delhi: The Modi government on Wednesday virtually halved the number of beneficiaries under its Maternity Benefit Programme (MBP) by restricting the scheme to firstborns instead of 'first two live births' as applicable earlier. PTI had earlier reported that reduced allocation of funds of Rs. 2700 crore for the scheme in the Union...
More »Indian generics bringing down global price of hepatitis C drugs, finds WHO -Himani Chandna
-Hindustan Times India’s generic drug manufacturers have flooded the market with cheaper medicines to treat hepatitis C after Gilead Sciences Inc’s patent application was rejected in January 2015. Thanks to domestic drugmakers, the world is looking to India to reduce the price of hepatitis C drug further. “By scaling up the production of generic medicines, India is playing a pivotal role globally in reducing the prices of medicines for hepatitis C,” said Henk...
More »
